Follansbee SE - Search Results

1

Activation of virus replication after vaccination of HIV-1-infected individuals.

Staprans SI, Hamilton BL, Follansbee SE, Elbeik T, Barbosa P, Grant RM, Feinberg MB. Staprans SI, et al. Among authors: follansbee se. J Exp Med. 1995 Dec 1;182(6):1727-37. doi: 10.1084/jem.182.6.1727. J Exp Med. 1995. PMID: 7500017 Free PMC article. Clinical Trial.

2

Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome.

Erlich KS, Mills J, Chatis P, Mertz GJ, Busch DF, Follansbee SE, Grant RM, Crumpacker CS. Erlich KS, et al. Among authors: follansbee se. N Engl J Med. 1989 Feb 2;320(5):293-6. doi: 10.1056/NEJM198902023200506. N Engl J Med. 1989. PMID: 2536136 No abstract available.

3

Oral ganciclovir for cytomegalovirus infections.

Follansbee SE, Stempien MJ, Buhles WC. Follansbee SE, et al. Adv Exp Med Biol. 1996;394:93-103. doi: 10.1007/978-1-4757-9209-6_11. Adv Exp Med Biol. 1996. PMID: 8815713 Review. No abstract available.

4

The efficacy of an anti-CD4 monoclonal antibody for HIV-1 treatment.

Fessel WJ, Anderson B, Follansbee SE, Winters MA, Lewis ST, Weinheimer SP, Petropoulos CJ, Shafer RW. Fessel WJ, et al. Among authors: follansbee se. Antiviral Res. 2011 Dec;92(3):484-7. doi: 10.1016/j.antiviral.2011.09.010. Epub 2011 Oct 4. Antiviral Res. 2011. PMID: 22001594 Free PMC article.

5

Pharmacokinetic, safety, and antiviral profiles of oral ganciclovir in persons infected with human immunodeficiency virus: a phase I/II study. AIDS Clinical Trials Group, and Cytomegalovirus Cooperative Study Group.

Spector SA, Busch DF, Follansbee S, Squires K, Lalezari JP, Jacobson MA, Connor JD, Jung D, Shadman A, Mastre B, et al. Spector SA, et al. J Infect Dis. 1995 Jun;171(6):1431-7. doi: 10.1093/infdis/171.6.1431. J Infect Dis. 1995. PMID: 7769276 Clinical Trial.

6

Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy.

Kantor R, Shafer RW, Follansbee S, Taylor J, Shilane D, Hurley L, Nguyen DP, Katzenstein D, Fessel WJ. Kantor R, et al. AIDS. 2004 Jul 23;18(11):1503-11. doi: 10.1097/01.aids.0000131358.29586.6b. AIDS. 2004. PMID: 15238768 Free PMC article.

7

High-density lipoprotein cholesterol is low in HIV-infected patients with lipodystrophic fat expansions: implications for pathogenesis of fat redistribution.

Fessel WJ, Follansbee SE, Rego J. Fessel WJ, et al. Among authors: follansbee se. AIDS. 2002 Sep 6;16(13):1785-9. doi: 10.1097/00002030-200209060-00011. AIDS. 2002. PMID: 12218390 Clinical Trial.

8

The dying process.

Follansbee SE. Follansbee SE. Focus. 1996 Jan;11(2):5-6. Focus. 1996. PMID: 11363151

9

Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group.

Spector SA, McKinley GF, Lalezari JP, Samo T, Andruczk R, Follansbee S, Sparti PD, Havlir DV, Simpson G, Buhles W, Wong R, Stempien M. Spector SA, et al. N Engl J Med. 1996 Jun 6;334(23):1491-7. doi: 10.1056/NEJM199606063342302. N Engl J Med. 1996. PMID: 8618603 Free article. Clinical Trial.

10

Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS). An uncontrolled trial.

Erlich KS, Jacobson MA, Koehler JE, Follansbee SE, Drennan DP, Gooze L, Safrin S, Mills J. Erlich KS, et al. Among authors: follansbee se. Ann Intern Med. 1989 May 1;110(9):710-3. doi: 10.7326/0003-4819-110-9-710. Ann Intern Med. 1989. PMID: 2522751

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters